Overview

Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

Status:
Active, not recruiting

Trial end date:
2024-02-29

Target enrollment:

Participant gender:

Summary

Primary Objective: To compare 3-year disease free survival (DFS) of tegafur-uracil following adjuvant oxaliplatin-based regimen to observation following adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection. Secondary Objectives: - To assess 5-year overall survival (OS) in each arm - To assess the safety profiles

Phase:

N/A

Details

Lead Sponsor:

Kaohsiung Medical University Chung-Ho Memorial Hospital

Treatments:

Oxaliplatin
Tegafur